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cell therapy protects against lung and kidney
injury in sepsis syndrome caused by cecal ligation
puncture in rats
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Introduction: We tested the hypothesis that apoptotic adipose-derived mesenchymal stem cells (A-ADMSC) are
superior to healthy (H)-ADMSC in attenuating cecal ligation puncture (CLP)-induced sepsis-mediated lung and
kidney injuries.
Methods: Adult male rats divided into group 1 (sham controls), group 2 (CLP), group 3 [CLP + H-ADMSC
administered at 0.5, 6, and 18 hours after CLP], and group 4 [CLP + A-ADMSC administered as in group 3]
were sacrificed 72 hours after CLP with blood, lung, and kidney collected for studies.
Results: White blood cell (WBC) count, circulating TNF-α and creatinine levels were higher in groups 2 and 3
than in groups 1 and 4 (all P < 0.001). Kidney and lung damage scores were highest in group 2, lowest in group
1, significantly higher in group 3 than in group 4 (all P < 0.0001). Protein expressions of inflammatory (ICAM-1,
MMP-9, TNF-α, NF-κB), oxidative, and apoptotic (Bax, caspase-3, PARP) biomarkers were higher in groups 2 and 3
than groups 1 and 4, whereas anti-apoptotic (Bcl-2) and mitochondrial integrity (cytochrome-C) biomarkers were
lower in groups 2 and 3 than in groups 1 and 4 (all P < 0.001). Expressions of anti-oxidant biomarkers at protein
(GR, GPx, NQO-1, HO-1) and cellular (GR, GPx) levels were highest in group 4 (all P < 0.001). The number of inflammatory
cells (CD3+) in lungs and levels of DNA damage marker (γ-H2AX) in kidneys were higher in groups 2 and 3 than in
groups 1 and 4 (all P < 0.001).
Conclusions: A-ADMSC therapy was superior to H-ADMSC therapy in protecting major organs from damage in rats
with CLP-induced sepsis syndrome.Introduction
Despite the state-of-the-art treatment strategies and
advanced antibiotic regimens, acute sepsis syndrome,
a global problem, remains the leading cause of death
in hospitalized patients with infectious disease [1-4].
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reproduction in any medium, provided the orprocess with the involvement of divergent factors [5-7].
Of these factors, overwhelming immune response (that
is, host response) and inflammatory reaction [4-6] are
major contributors to direct or indirect assaults on the
vital organs [8-11]. In addition, studies have shown that
sepsis syndrome-related acute lung injury (ALI) and
acute kidney injury (AKI) are commonly encountered
in critically ill patients [10]. Poor prognostic outcomes
have been reported for patients in these clinical settings
[6,9-15]. Therefore, in addition to the appropriate choice
of antibiotics [1,2], the control of the overwhelming
immune response and vigorous inflammatory reaction
that contribute to the damage of lung and kidney, twotd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sepsis-induced morbidity and mortality [5-7].
Not only has growing evidence demonstrated that stem
cells possess the intrinsic capacity of immunomodulation
[15-17], but stem cell therapy has also been shown to
attenuate inflammation and immune responses [15-19] and
augment wound healing cells to favor tissue regeneration
and inhibit fibrotic tissue formation [19]. Additionally,
utilizing three-dimensional culture models, stem cells
have been shown to have the capacity of tissue formation
and organ reconstruction [20]. Also, it has been proposed
that apoptotic/dying stem cells exhibit distinctive immuno-
suppressive properties [21]. Moreover, our data recently
showed that apoptotic adipose-derived mesenchymal
stem cells (A-ADMSC) were superior to healthy ADMSC
(H-ADMSC) in attenuating acute lung ischemia-reperfu-
sion (IR) injury in rats through suppressing inflammation,
oxidative stress, reactive oxygen species (ROS) generation
and immune response [22].
Experimental studies have previously demonstrated that,
in the setting of sepsis syndrome, stem cell treatment
notably alleviated sepsis-induced inflammatory reaction,
decreased mortality and improved prognostic outcome
[23-25]. Additionally, in another recent study we showed
that A-ADMSC therapy was superior to H-ADMSC
therapy for preserving heart function and reducing
mortality in rat sepsis syndrome [26]. Therefore, it is rational
to believe that there is a potentially more important role
for A-ADMSC therapy for sepsis syndrome. However,
whether A-ADMSC is superior H-ADMSC in protecting
the kidney and lung against sepsis syndrome-associated
injuries is currently unclear. It is well recognized that
appendicitis-induced peritonitis is one of the most
common clinically encountered sepsis syndromes in
our daily practice. Accordingly, using a rodent model
of cecal ligation and puncture (CLP)-induced sepsis
syndrome, this study tested the hypotheses that: (1)
CLP-induced sepsis syndrome may significantly con-
tribute to ALI and AKI; (2) ADMSC treatment may
significantly attenuate sepsis-induced kidney and lung
injuries; and (3) A-ADMSC may be superior to H-
ADMSC in reducing sepsis syndrome-associated lung
and kidney injury.Methods
Ethics
All animal experimental procedures were approved by
the Institute of Animal Care and Use Committee at our
hospital and performed in accordance with the Guide for
the Care and Use of Laboratory Animals (NIH publication
No. 85–23, National Academy Press, Washington, DC,
USA, revised 1996). All technicians who performed the
bench work were blinded to the treatment protocol.Animal grouping and isolation of adipose tissue for
culturing adipose-derived mesenchymal stem cells
Pathogen-free, adult male Sprague–Dawley (SD) rats
weighing 350 to 400 g (Charles River Technology, Bio-
LASCO Taiwan Co. Ltd., Yilan, Taiwan) were categorized
into sham procedure (SC) (that is, cecal exposure without
ligature and puncture), CLP only (CLP + saline 3.0 mL,
intra-peritoneally at 30 minutes, 6 hours, and 18 hours
after CLP), CLP +H-ADMSC ((autologous 1.2 × 106 cells) at
30 minutes, 6 hours, and 18 hours after CLP), and CLP +A-
ADMSC ((autologous 1.2 × 106 cells) at 30 minutes, 6 hours,
and 18 hours after CLP); n = 8 animals per group.
The choice of time points of ADMSCs administration
at 30 minutes, 6 hours, and 18 hours after CLP was based
on our recent study that demonstrated that ADMSC
administration at these time points after acute rat kidney
IR injury through penile venous transfusion markedly
attenuated acute ischemia/reperfusion-induced kidney
injury [16]. In addition, these time points were initially
chosen in an attempt to mimic the clinical scheduling
of antibiotics for patients with sepsis syndrome.
Rats in groups CLP +H-ADMSC and CLP +A-ADMSC
were anesthetized with inhalational 2.0% isoflurane 14
days before CLP to harvest autologous peri-epididymal
adipose tissue as we recently reported [16]. The procedure
and protocol for culture and identification of H-ADMSCs
and A-ADMSCs were described in our recent reports
[16,18,22]. Briefly, the adipose tissue surrounding the
epididymis was carefully dissected and excised. Then
200 to 300 μL of sterile saline was added to every 0.5 g
of tissue to prevent dehydration. The tissue was cut
into <1 mm3 size pieces using a pair of sharp, sterile
surgical scissors. Sterile saline (37˚C) was added to the
homogenized adipose tissue in a ratio of 3:1 (saline:
adipose tissue) by volume, followed by the addition of
stock collagenase solution to a final concentration of
0.5 Units/mL. The tubes with the contents were placed
and secured on a Thermaline shaker and incubated with
constant agitation for 60 ± 15 minutes at 37°C. After 40
minutes of incubation, the contents were triturated with a
25 mL pipette for 2 to 3 minutes. The cells obtained were
placed back on the rocker for incubation. The contents of
the flask were transferred to 50 mL tubes after digestion,
followed by centrifugation at 600 g for 5 minutes at room
temperature. The lipid layer and saline supernatant from
the tube were poured out gently in one smooth motion or
removed using vacuum suction. The cell pellet thus ob-
tained was resuspended in 40 mL saline and then centri-
fuged again at 600 g for 5 minutes at room temperature.
After being resuspended again in 5 mL saline, the cell sus-
pension was filtered through a 100 μm filter into a 50 mL
conical tube to which 2 mL of saline was added to rinse the
remaining cells through the filter. The flow-through was pi-
petted to a 40 μm filter into a new 50 mL conical tube. The
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nutes at room temperature. The cells were resuspended in
saline. Isolated ADMSCs were cultured in a 100 mm diam-
eter dish with 10 mL (D)MEM culture medium containing
10% fetal bovine serum (FBS) for 14 days.
The procedures of cecal ligation and puncture and
measurement of tail systolic blood pressure
Rats were anesthetized with inhalational 2.0% isoflurane
and placed in a supine position on a warming pad at 37°C
with the abdomen shaved. Under sterile conditions, the
abdominal skin and muscle were opened and the cecum
exposed in all groups. In the sham controls, the abdomen
was then closed and the animal was allowed to recover
from anesthesia. In the experimental CLP groups, the
cecum was prolene suture ligated over its distal portion
(that is, distal ligation) and the cecum distal to the ligature
was punctured twice with an 18G needle to allow the cecal
contents to be expressed intraperitoneally, as previously
described [27]. The abdominal wound was closed and the
animal was allowed to recover from anesthesia.
The tail systolic blood pressure (SBP) was measured
(Kent Scientific Corporation, Model no: CODA, Torring-
ton, CT, USA.) by a technician who was blinded to the
treatment protocols prior to and at 9 hours and 18 hours
after CLP or the sham procedure. The tail cuff approach
to blood pressure measurement was conducted as follows:
initially the rat was warmed in a box at 37°C for 20 mi-
nutes before being placed in a restraining apparatus
which was also kept at 37°C. The tail was inserted
through the cuff which contained a photoelectric pulse
detector through which the systolic blood pressure was
recorded when the first oscillation appeared during the
gradual reduction of cuff pressure. Mean blood pressure
was determined from the cuff pressure when the ampli-
tude of the oscillation reached its maximum. The SBP
was consecutively and continuously measured 30 times
in each rat. The value of SBP recorded for the first 10
times and those recorded when the animals were agitated
were discarded. Finally, reliable SBP readings were aver-
aged for each rat and expressed as mean ± SD.
Definition of healthy and apoptotic ADMSCs
Healthy ADMSCs were those cultured in normal culture
medium with adequate nutrition. Serum deprivation of
cells in vitro induces apoptosis [22,28]. Hence, apoptotic
ADMSCs were first cultured in normal culture medium
followed by 96 hours of serum-free cell culture. The per-
centages of viable and apoptotic cells were determined
by flow cytometry using double staining of annexin V
and propidium iodide (PI); this is a simple and popular
method for the identification of apoptotic cells (that is
early (annexin V+/PI-) and late (annexin V+/PI+) phases
of apoptosis).The principal concept in the present study for the
induction of A-ADMSCs using ‘serum deprivation’ is to
artificially create a ‘stress environment’ that would activate
an intra-cellular signaling pathway for secreting cytokines/
chemokines and other mediators to seek the survival path.
Analyses of circulating levels of creatinine and
inflammatory biomarkers
Blood samples were stored at −80°C until analyses of tumor
necrosis factor (TNF)-α and creatinine were performed in
batches at the end of the experiment. Serum TNF-α concen-
tration was assessed in duplicate with a commercially avail-
able ELISA kit (R&D Systems, Inc. Minneapolis, MN, USA).
Intra-individual variability in TNF-α level was assessed in
each group. The mean intra-assay coefficients of variance
were all less than 4.0%. Circulating levels of creatinine and
white blood cell (WBC) count were measured prior to and
at 72 hours after CLP with standard laboratory methods.
Histopathology scoring of kidney injury at 72 hours after
the CLP procedure
Histopathology scoring was determined in blinded fashion
as previously reported [18]. Briefly, the kidney specimens
from all animals were fixed in 10% buffered formalin,
embedded in paraffin, sectioned at 5 mm and stained
(hematoxylin and eosin; H & E) for light microscopy.
The score reflected the grading of tubular necrosis, loss
of brush border, cast formation and tubular dilatation
in 10 randomly chosen, non-overlapping fields (200x)
for each animal as follows: 0 (none), 1 (≤10%), 2 (11%
to 25%), 3 (26% to 45%), 4 (46% to 75%) and 5 (≥76%).
Histological assessment of lung injury and crowded score
for lung parenchyma
To identify alveolar sac distribution in lung parenchyma,
the lung specimens from all animals were fixed in 10%
buffered formalin before embedding in paraffin; tissues
were sectioned at 5 μm for light microscopy. H & E
staining was performed to determine the number of
alveolar sacs in a blinded fashion as we previously
reported [16]. Three lung sections from each rat were
analyzed and three randomly selected high-power fields
(HPFs; 100x) were examined in each section. The mean
number per HPF for each animal was then determined
by summation of all numbers divided by 9. The extent
of crowded area, which was defined as the region of
thickened septa in lung parenchyma associated with partial
or complete collapse of alveoli on H & E-stained sections,
was also performed in a blinded fashion. The following
scoring system [16] was adopted: 0 = no detectable
crowded area; 1 = <15% of crowded area; 2 = 15% to
25% of crowded area; 3 = 25% to 50% of crowded area;
4 = 50% to 75% of crowded area; 5 = >75% to 100% of
crowded area/per HPF.
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The procedures and protocols for immunohistochemical
(IHC) and immunofluorescent (IF) examinations were
also based on our recent study [16]. Briefly, for IHC
staining, rehydrated paraffin sections were first treated
with 3% H2O2 for 30 minutes and incubated with Immuno-
Block reagent (BioSB, Santa Barbara, CA, USA) for 30 mi-
nutes at room temperature. Sections were then incubated
with primary antibodies specifically against glutathione
peroxidase (GPx; 1:500, Abcam, Cambridge, MA, USA)
glutathione reductase (GR; 1:100, Abcam, Cambridge,
MA, USA) and phosphorylated H2AX (γ-H2AX, Cell sig-
naling, Danvers, MA, USA) at 4°C overnight. Irrelevant
antibodies (p53 (1:500, Abcam, Cambridge, MA, USA)
and mouse control immunoglobulin G (IgG, Abcam,
Cambridge, MA, USA)) provided controls in the
current study. IF staining was performed for the exam-
inations of CD31 (1:200, SeroTec, Raleigh, NC, USA)
using the respective primary antibody; again, irrelevant
antibodies were used as controls. Three sections of
lung and kidney specimens were analyzed in each rat. For
quantification, three randomly selected HPFs (x200 for
IHC and IF studies) were analyzed in each section. The
mean number per HPF for each animal was then deter-
mined by summation of all numbers divided by 9. An
IHC-based scoring system was adopted for semi-
quantitative analyses of GR and GPx in kidney as a per-
centage of positive cells in blinded fashion (score of
positively-stained cells for GR and GPx: 0 = no stain;
1 = <15%; 2 = 15% to approximately 25%; 3 = 25% to ap-
proximately 50%; 4 = 50% to approximately 75%; 5 =
>75% to 100%/per HPF).Table 1 Blood pressure, hematologic and biochemical studies
Variables Group 1 Group
Systolic blood pressure (mmHg)
At 0 hour 125.8 ± 5.5 123.4 ±
At 72 hours 129.1 ± 7.6a 102.6 ± 5
At 24 hours
Creatinine 0.51 ± 0.12 0.77 ± 0
WBC count 8.1 ± 2.0 4.9 ± 2
At 72 hours
Creatinine 0.5 ± 0.07a 0.78 ± 0.
WBC count 7.7 ± 1.9a 12.6 ± 2
Serum TNF-α level (ng/mL)
At 0 hour 1.92 ± 0.81 1.89 ± 1
At 24 hours 2.16 ± 1.46a 11.6 ± 2.
At 72 hours 2.4 ± 1.58a 5.92 ± 1.
Data are expressed as means ± SD. Group 1, sham control; group 2, cecal ligation a
cell (H-ADMSC); group 4, CLP + adipose (A)-ADMSC. Symbols (a, b, c) indicate signific
WBC, white blood cells.Western blot analysis of left lung specimens
Equal amounts (10 to 30 μg) of protein extracts from
the left lung were loaded and separated by SDS-PAGE
using 8% to 10% acrylamide gradients. Following elec-
trophoresis, the separated proteins were transferred
electrophoretically to a polyvinylidene difluoride (PVDF)
membrane (Amersham Biosciences, Piscataway, NJ, USA).
Nonspecific proteins were blocked by incubating the mem-
brane in blocking buffer (5% nonfat dry milk in T-TBS con-
taining 0.05% Tween 20) overnight. The membranes were
incubated with monoclonal antibodies against intercellular
adhesion molecule (ICAM)-1 (1: 2000, Abcam, Cam-
bridge, MA, USA), polyclonal antibodies against TNF-α
(1: 1000, Cell Signaling, Danvers, MA, USA), nuclear
factor (NF)-κB (1: 250, Abcam, Cambridge, MA, USA),
metalloproteinase-9 (MMP-9) (1:3000, Abcam, Cam-
bridge, MA, USA), GR (1:1000, Abcam, Cambridge,
MA, USA), GPx (1:1000, Abcam, Cambridge, MA, USA),
Cytochrome C (1:2000, BD, San Jose, CA, USA), NAD(P)H
quinone oxidoreductase (NQO) 1 (1: 1000, Abcam, Cam-
bridge, MA, USA), heme oxygense (HO)-1 (1: 250,
Abcam, Cambridge, MA, USA), Bax (1: 1000, Abcam,
Cambridge, MA, USA), caspase 3 (1: 1000, Cell Signal-
ing), poly (ADP-ribose) polymerase (PARP) (1: 1000,
Cell Signaling, Danvers, MA, USA) and Bcl-2 (1:250,
Abcam, Cambridge, MA, USA). Signals were detected
with horseradish peroxidase (HRP)-conjugated goat anti-
mouse, goat anti-rat or goat anti-rabbit IgG.
The Oxyblot Oxidized Protein Detection Kit was pur-
chased from Chemicon (S7150, Billerica, MA, USA). The
procedure of 2,4-dinitrophenylhydrazine (DNPH) derivati-
zation was carried out on 6 μg of protein for 15 minutesamong the four groups
2 Group 3 Group 4 P-value
4.7 119.5 ± 4.6 117.5 ± 4.2 0.647
.6b 82.1 ± 5.8c 119. 1 ± 7.7a <0.001
.15 0.74 ± 0.25 0.66 ± 0.14 0.051
.6 7.7 ± 2.5 6.8 ± 1.4 0.057
14b 0.83 ± 0.17b 0.61 ± 0.11a <0.001
.8b 9.2 ± 3.1c 9.5 ± 2.3c 0.016
.04 2.13 ± 1.18 2.22 ± 1.40 0.887
72b 15.9 ± 5.4c 12.21 ± 5.81b <0.001
92b 8.53 ± 8.56b 4.24 ± 1.27c <0.001
nd puncture (CLP); group 3, CLP + healthy adipose-derived mesenchymal stem
ant difference (at 0.05 level) by Bonferroni multiple-comparison post hoc test.
Figure 1 Flow cytometric results of cellular apoptosis and Western blot results of oxidative stress. A) Compares the incidence of early
(annexin V+/PI-) and late (annexin V+/PI+) phases of apoptosis between healthy adipose-derived mesenchymal stem cells (H-ADMSC) and apoptotic
(A) (that is, 96 hours of serum-free cell culture) ADMSC (A-ADMSC). B) For A-ADMSCs, early apoptosis and late apoptosis increased at 24 hours
and further increased by 48 hours after re-culture (after 96 hours of serum-free cell culture) in normal culture medium with adequate nutrition.
* versus H-ADMSC in early or late phase of cellular apoptosis, P <0.0001. C) DAPI stain (nuclei were stained in blue color) indicated the cell
apoptosis (white arrows). Apoptosis (white arrows) in A-ADMSC was markedly increased at 48 hours after being re-cultured in normal culture
medium with adequate nutrition. D and E) Oxidized protein in lung (D) and kidney (E) at 72 hours after cecal ligation and puncture (CLP)
procedure. DNP, 1–3 dinitrophenylhydrazone; M.W., molecular weight (Note: The right lane and left lane shown on the upper panel represent
control oxidized molecular protein standard and protein molecular weight marker, respectively). 1, sham control (SC); 2, cecal ligation and
puncture (CLP); 3, CLP + H-ADMSC; 4, CLP + A-DMSC. * versus other groups with different symbols, P <0.001. Statistical analysis using one-way
ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡) indicate significant difference (<0.05). ANOVA,
analysis of variance; DAPI, 4',6-diamidino-2-phenylindole.
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dimensional electrophoresis was carried out on 12%
SDS/polyacrylamide gel after DNPH derivatization. Pro-
teins were transferred to nitrocellulose membranes which
were then incubated in the primary antibody solution
(anti-DNP 1:150) for two hours, followed by incubation
with the secondary antibody solution (1:300) for one hour
at room temperature. The washing procedure was re-
peated eight times within 40 minutes.
Immunoreactive bands were visualized by enhanced
chemiluminescence (ECL; Amersham Biosciences), which
was then exposed to Biomax L film (Kodak). For quantifi-
cation, ECL signals were digitized using Labwork software
(UVP). For oxyblot protein analysis, a standard control
was loaded on each gel.
Statistical analyses
Quantitative data are expressed as mean ± SD. Statistical
analysis was performed by analysis of variance (ANOVA)Figure 2 Protein expressions of MMP-9 and ICAM-1 in lung and kidne
expression of matrix metalloproteinase (MMP)-9 in lung (A) and kidney (B)
kidney: * versus other groups with different symbols, P <0.001. C and D) Th
lung (C) and kidney (D). For lung: * versus other groups with different symbo
P <0.001. Statistical analysis using one-way ANOVA, followed by the Bonferron
significant difference (<0.05). SC, sham control; CLP, cecal ligation and punctu
apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variancfollowed by the Bonferroni multiple-comparison post hoc
test. All analyses were conducted using SAS statistical
software for Windows version 8.2 (SAS Institute, Cary,
NC, USA). A probability value <0.05 was considered
statistically significant.
Results
Systolic blood pressure at 0 and 72 hours after CLP/SP
The SBP did not differ among the four groups at 0 hour
after the CLP procedure. However, by 72 hours after the
procedure, SBP was lowest in CLP +H-ADMSC, signifi-
cantly lower in CLP only than in sham control (SC) and
CLP + A-ADMSC, and similar between SC and CLP + A-
ADMSC (Table 1).
Circulating levels of creatinine and inflammatory
biomarkers after the CLP procedure
At 24 hours after the CLP procedure, the serum creatinine
level and WBC count did not differ among all groupsy at 72 hours after the CLP procedure. A and B) The protein
. For lung: * versus other groups with different symbols, P <0.001. For
e protein expressions of intercellular adhesion molecule (ICAM)-1 in
ls, P <0.001. For kidney: * versus other groups with different symbols,
i multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §) indicate
re; H-ADMSC, healthy adipose-derived mesenchymal stem cell; A-ADMSC,
e.
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serum creatinine level was significantly higher in CLP only
and CLP +H-ADMSC than in SC and CLP +A-ADMSC,
but there was no significant difference between CLP only
and CLP +H-ADMSC or between SC and CLP +A-
ADMSC (Table 1). In addition, the WBC count was signifi-
cantly highest in CLP only, significantly higher in CLP +
H-ADMSC and CLP +A-ADMSC than in SC, but it ex-
hibited no difference between CLP +H-ADMSC and CLP
+A-ADMSC at 72 hours after the procedure (Table 1).
The circulating level of TNF-α was similar among the
four groups prior to the procedure, whereas it was high-
est in CLP +H-ADMSC, significantly higher in groups
CLP only and CLP + A-ADMSC than in SC, but it
displayed no difference between groups CLP only and
CLP + A-ADMSC at 24 hours after the procedure
(Table 1). Moreover, it was significantly higher in CLP
only and CLP + H-ADMSC than SC and CLP + A-
ADMSC, significantly higher in CLP + A-ADMSC thanFigure 3 Protein expression of TNF-α and NF-κB in lung and kidney a
expression of tumor necrosis factor alpha (TNF-α) in lung (A) and kidney
For kidney: * versus other groups with different symbols, P <0.001. C and
and kidney (D). For lung: * versus other groups with different symbols, P
P <0.0001. Statistical analysis using one-way ANOVA, followed by the Bon
indicate significant difference (<0.05). SC, sham control; CLP, cecal ligatio
stem cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. Ain SC, but it showed no difference between CLP only
and CLP + H-ADMSC at 72 hours after the procedure
(Table 1).
Flow cytometric analysis of apoptosis and protein
expressions of inflammatory biomarkers in lung and
kidney at 72 hours after the CLP procedure
Flow cytometric analyses demonstrated that early
apoptosis (annexin V+/PI-) and late apoptosis (annexin
V+/PI+) were significantly higher in the A-ADMSC
group (that is, by 96 hours of serum-free cell culture)
than in the H-ADMSC group (Figure 1A, 1B). Inter-
estingly, in the A-ADMSC group, the proportion of
cells in early apoptosis (annexin V+/PI-) and late apop-
tosis (annexin V+/PI+) was increased at 24 hours, and
further increased by 48 hours after re-culture (after 96
hours of serum-free cell culture) in normal culture
medium with adequate nutrition. These findings might
suggest that a certain percentage of A-ADMSC wouldt 72 hours after the CLP procedure. A and B) The protein
(B). For lung: * versus other groups with different symbols, P <0.001.
D) The protein expression of nuclear factor (NF)- κB in lung (C)
<0.001. For kidney: * versus other groups with different symbols,
ferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §)
n and puncture; H-ADMSC, healthy adipose-derived mesenchymal
NOVA, analysis of variance.
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circulation, especially in the setting of sepsis syndrome.
By 72 hours after the three time points of ADMSC treat-
ment (that is, 1.2 × 106 of H-ADMSCs or A-ADMSCs
at time points of 0.5 hour, 6 hours, and 18 hours after
the CLP procedure), the expressions of oxidized pro-
tein in lung (Figure 1C, 1D) and kidney (Figure 1E,
1F), an index of oxidative stress, were significantly
higher in CLP only and CLP + H-ADMSC than in SC
and CLP +A-ADMSC, and significantly higher in CLP +
A-ADMSC than in SC, but there was no difference
between CLP only and CLP + H-ADMSC.
Additionally, the protein expression of MMP-9 in lung
parenchyma, an index of inflammation, was highest in CLP
only, significantly higher in CLP +H-ADMSC than in SC
and CLP +A-ADMSC, but there was no difference be-
tween SC and CLP +A-ADMSC (Figure 2A). In addition,
its expression in kidney parenchyma was significantlyFigure 4 The protein expressions of apoptotic biomarkers in lung and
protein expression of cleaved caspase 3 (C-Csp3) in lung (A) and kidney
P <0.001. For kidney: * versus other groups with different symbols, P <0
polymerase (C-PARP) in lung (C) and kidney (D). For lung: * versus othe
other groups with different symbols, P <0.001. Statistical analysis using
post hoc test (n = 8). Symbols (*, †, ‡, §) indicate significant difference (<
H-ADMSC, healthy adipose-derived mesenchymal stem cell; A-ADMSC, a
analysis of variance.higher in groups CLP only and SC and CLP +H-ADMSC
than in SC and CLP +A-ADMSC, and significantly higher
in CLP +A-ADMSC than in SC, but it exhibited no differ-
ence between CLP only and CLP +H-ADMSC (Figure 2B).
The protein expression of ICAM-1, another inflamma-
tory biomarker, in lung parenchyma, was significantly
higher in CLP only than in the other groups, signifi-
cantly higher in CLP + H-ADMSC than in groups SC
and CLP + A-ADMSC, but it did not differ between SC
and CLP + A-ADMSC (Figure 2C). Accordingly, its ex-
pression in kidney parenchyma showed a similar pattern
to that of oxidized protein expression among the four
groups (Figure 2D).
Moreover, the protein expressions of TNF-α and NF-κB,
two inflammatory biomarkers in lung and kidney paren-
chyma, were highest in CLP +H-ADMSC, lowest in SC,
significantly higher in CLP only than in CLP +A-ADMSC
(Figure 3A, 3B, 3C, 3D).kidney at 72 hours after the CLP procedure. A and B) The
(B). For lung: * versus other groups with different symbols,
.001. C and D) The protein expression of cleaved poly (ADP-ribose)
r groups with different symbols, P <0.0001. For kidney: * versus
one-way ANOVA, followed by the Bonferroni multiple comparison
0.05). SC, sham control; CLP, cecal ligation and puncture;
poptotic adipose-derived mesenchymal stem cell. ANOVA,
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biomarkers at 72 hours after the CLP procedure
The protein expression of cleaved (that is, active form)
caspase 3 in lung and kidney, an index of apoptosis, was
significantly higher in CLP only and CLP +H-ADMSC
than in SC and CLP +A-ADMSC, and significantly higher
in CLP +A-ADMSC than in SC (Figure 4-A, 4-B). In
addition, this parameter in kidney was significantly higher
in CLP only than in CLP +H-ADMSC, whereas there was
no difference in lung parenchyma between CLP only
and CLP +H-ADMSC (Figure 4A, 4B). Furthermore, the
protein expression of PARP in lung (4-C) and kidney
(4-D), the substrate of caspase 3, was highest in CLP
only, lowest in SC, and significantly higher in CLP + H-
ADMSC than in CLP + A-ADMSC.
The mitochondrial Bax protein expression in lung
and kidney parenchyma, an indicator of apoptosis, was
significantly higher in CLP only and CLP + H-ADMSC
than in SC and CLP + A-ADMSC (Figure 5A, 5B).Figure 5 The protein expressions of apoptotic and anti-apoptotic bio
A and B) The protein expression of mitochondrial (Mito) Bax in lung (A) an
P <0.01. For kidney: * versus other groups with different symbols, P <0.01. C
For lung: * versus other groups with different symbols, P <0.001. For kidney: *
using one-way ANOVA, followed by the Bonferroni multiple comparison
(<0.05). SC, sham control; CLP, cecal ligation and puncture; H-ADMSC, he
adipose-derived mesenchymal stem cell. ANOVA, analysis of variance.Additionally, this parameter was significantly higher in
CLP + A-ADMSC than in SC in kidney parenchyma,
but it exhibited no difference between SC and CLP +
A-ADMSC in lung parenchyma (Figure 5A, 5B). On
the other hand, the protein expression of Bcl-2, an
indicator of anti-apoptosis, was significantly lower in
CLP only and CLP + H-ADMSC than in SC and CLP +
A-ADMSC, but it did not differ between CLP only and
CLP + H-ADMSC or between SC and CLP + A-ADMSC
(Figure 5C, 5D).
The protein expressions of anti-oxidant biomarkers at 72
hours after the CLP procedure
The protein expression of GR in the lung, an indicator
of anti-oxidation, did not differ among the four groups
(Figure 6A). However, this protein expression in the kidney
was lowest in SC and highest in CLP + A-ADMSC, but
there was no significant difference between CLP only
and CLP + H-ADMSC (Figure 6B). Additionally, themarkers in lung and kidney at 72 hours after the CLP procedure.
d kidney (B). For lung: * versus other groups with different symbols,
and D) The protein expression of Bcl-2 in lung (C) and kidney (D).
versus other groups with different symbols, P <0.01. Statistical analysis
post hoc test (n = 8). Symbols (*, †, ‡) indicate significant difference
althy adipose-derived mesenchymal stem cell; A-ADMSC, apoptotic
Figure 6 The protein expression of GR and GPx in lung and kidney at 72 hours after the CLP procedure. A and B) The protein expression
of glutathione reductase (GR) in lung (A) and kidney (B). For lung: * versus other groups with different symbols, P >0.1. For kidney: * versus other
groups with different symbols, P <0.001. C and D) The protein expression of glutathione peroxidase (GPx) in lung (C) and kidney (D). For lung:
* versus other groups with different symbols, P <0.008. For kidney: * versus other groups with different symbols, P <0.0001. Statistical analysis using
one-way ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §) indicate significant difference (<0.05). SC,
sham control; CLP, cecal ligation and puncture; H-ADMSC, healthy adipose-derived mesenchymal stem cell; A-ADMSC, apoptotic adipose-derived
mesenchymal stem cell. ANOVA, analysis of variance.
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CLP + A-ADMSC, significantly higher in CLP only
and CLP + H-ADMSC than in SC, but there was no
difference between CLP only and CLP + H-ADMSC
(Figure 6C). Furthermore, its expression in the kidney
was lowest in SC, highest in CLP + A-ADMSC, signifi-
cantly higher in CLP + H-ADMSC than in CLP only
(Figure 6D).
The protein expressions of HO-1 (7-A) and NQO 1
(7-C) in lung, another two indices of anti-oxidation,
were significantly higher in CLP + A-ADMSC than in
other groups, significantly higher in CLP only and CLP +
H-ADMSC than in SC, but there was no notable
difference between CLP only and CLP + H-ADMSC.
Moreover, the expressions of these two parameters in
kidney were lowest in SC, highest in CLP + A-ADMSC,
and significantly higher in CLP +H-ADMSC than in CLP
only (Figure 7B, 7D).The protein expressions of markers of mitochondrial
integrity and DNA damage at 72 h after CLP procedure
Protein expression of mitochondrial cytochrome C, an in-
dicator of mitochondrial integrity in lung, was significantly
higher in SC and CLP +A-ADMSC than in CLP only and
CLP +H-ADMSC, and significantly higher in SC than in
CLP +A-ADMSC, but it showed no difference between
CLP only and CLP +H-ADMSC (Figure 8A). Conversely,
the cytosolic expression of this biomarker, an index of
mitochondrial damage, was lowest in SC and highest in
CLP only, significantly higher in CLP + H-ADMSC than
in CLP + A-ADMSC (Figure 8C). Similarly, the mito-
chondrial level of this biomarker in kidney was signifi-
cantly higher in SC and CLP + A-ADMSC than in CLP
only and CLP + H-ADMSC, but there was no difference
between SC and CLP + A-ADMSC or between CLP
only and CLP + H-ADMSC (Figure 8B). Furthermore,
the cytosolic level of this biomarker in kidney showed
Figure 7 The protein expression of HO-1 and NQO 1 in lung and kidney at 72 hours after the CLP procedure. A and B) The protein
expression of heme oxygense (HO)-1 in lung (A) and kidney (B). For lung: * versus other groups with different symbols, P <0.0001. For kidney:
* versus other groups with different symbols, P <0.001. C and D) The protein expression of NAD(P)H quinone oxidoreductase (NQO) 1 in lung
(C) and kidney (D). For lung: * versus other groups with different symbols, P <0.001. For kidney: * versus other groups with different symbols,
P <0.001. Statistical analysis using one-way ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §)
indicate significant difference (<0.05). SC, sham control; CLP, cecal ligation and puncture; H-ADMSC, healthy adipose-derived mesenchymal stem
cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variance.
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four groups (Figure 8D).
IF staining of kidney parenchyma showed that the
population of γ-H2AX (+) cells, an indicator of DNA
damage, was highest in CLP only, lowest in SC and
significantly higher in CLP +H-ADMSC than in CLP +A-
ADMSC (Figure 8E to 8I).Histopathology of the kidney at 72 hours after the
CLP procedure
To determine the effects of H-ADMSC and A-ADMSC
treatment on the severity of CLP-induced renal injury,
a histological scoring system based on the typical micro-
scopic features of acute tubular damage (including exten-
sive tubular necrosis and dilatation, cast formation, and
loss of brush border) was adopted (Figure 9). This injury
score was highest in CLP only, significantly higher inCLP +H-ADMSC than in SC and CLP +A-ADMSC, and
significantly higher in CLP + A-ADMSC than in SC.
The expressions of anti-oxidative activity in the kidney at
72 hours after the CLP procedure
IHC staining demonstrated that the expressions of GR
(Figure 10A to 10E) and GPx (Figure 10F to 10J), two
oxidoreductase enzymes, were highest in CLP +A-ADMSC
and lowest in SC, and that of GPx was significantly higher
in CLP + H-ADMSC than in CLP only, but that of GR
did not differ between CLP only and CLP + H-ADMSC.
Immunohistochemical (IHC) staining of alveolar sacs,
crowded score and population of inflammatory cells in
the lung parenchyma at 72 hours after the CLP procedure
IHC staining showed that the number of alveolar sacs
was lowest in the CLP only group, significantly lower in
CLP + H-ADMSC than in SC and CLP + A-ADMSC
Figure 8 The protein expression of mitochondrial integrity in both lung and kidney and DNA damage marker in kidney at 72 hours
after the CLP procedure. A and B) The protein expression of mitochondrial cytochrome C (Mito-Cyt C) in lung (A) and kidney (B). For lung:
* versus other groups with different symbols, P <0.01. For kidney: * versus other groups with different symbols, P <0.001. C and D) The protein
expression of mitochondrial cytochrome C (Cyto-Cyt C) in lung (C) and kidney (D). For lung: * versus other groups with different symbols,
P <0.001. For kidney: * versus other groups with different symbols, P < 0.01. E to H) Immunofluorescent stain (400x) for γ-H2AX + cells (white arrows)
in kidney. I) Quantitative analysis of γ-H2AX + cells (%), P <0.0001). DAPI stain for identification of nuclei (blue color). Scale bars in the right lower corner
represent 20 μm. Statistical analysis using one-way ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §)
indicate significant difference (<0.05). SC, sham control; CLP, cecal ligation and puncture; H-ADMSC, healthy adipose-derived mesenchymal stem cell;
A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variance; DAPI, 4',6-diamidino-2-phenylindole.
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Figure 9 Histopathological scoring of kidney injury at 72 hours after the CLP procedure. A to D) H & E stain (400x) showing a significantly
higher degree of loss of brush border in renal tubules (yellow arrows), tubular necrosis (green asterisk) and dilatation of Bowman’s capsule (blue
arrows) in the CLP group than in the other groups. E) * versus other groups with different symbols (*, †, ‡, §), P <0.0001. All statistical analyses
using one-way ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §) indicate significance (at 0.05 level).
Scale bars in the right lower corner represent 20 μm. SC, sham control; CLP, cecal ligation and puncture; H-ADMSC, healthy adipose-derived
mesenchymal stem cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variance.
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(Figure 11A to 11E). Microscopically, the lung parenchyma
was most crowded in CLP only, significantly more crowded
in CLP +H-ADMSC than in SC and CLP +A-ADMSC,
and significantly more crowded in CLP +A-ADMSC than
in SC (Figure 11A to 11D, 11F).
IHC staining for the number of CD3+ cells, an index
of inflammatory cells in lung parenchyma, was highest
in CLP only and lowest in SC, significantly higher in
CLP + H-ADMSC than in CLP + A-ADMSC (Figure 11G
to 11K).
The protein expressions of inflammatory biomarkers in
the lung and kidney at 72 hours after the CLP procedure
after treatment with one dose of ADMSC
Interestingly, one recent study has shown that, as com-
pared to a lower dose of ADMSC, the higher dose of
ADMSC did not offer an additional benefit on attenuat-
ing lung injury in the sepsis syndrome setting [29]. In
addition, the results of the resent study demonstrated that
treatment with three doses of H-ADMSC was inconsistent
in suppressing the inflammatory mediators. Accordingly,
in order to elucidate whether one dose of H-ADMSC (that
is, 1.2 × 106 cells) was more suitable than three doses of
H-ADMSC for reducing inflammatory biomarkers in
lung and kidney parenchyma, an additional twenty four
SD rats were equally distributed into SC, CLP only, H-
ADMSC and A-ADMSC groups and received one low
dose (1.2 × 106 cells) of H-ADMSCs or A-ADMSCs at
30 minutes after the CLP procedure, respectively. Inter-
estingly, the protein expressions of oxidative stress,MMP-9, VCAM-1, TNF-α and NF-κB, in lung and kidney
parenchyma were highest in CLP only, lowest in SC,
and significantly higher in CLP + H-ADMSC than in
CLP + A-ADMSC at 72 hours after the CLP procedure
(Figure 12A to 12J). Our findings imply that one dose
of H-ADMSC was better and more consistent than
three time-points of strategic management (that is, high
dosage of ADMSCs) for reducing the sepsis-induced
kidney and lung injury.
The immunofluorescent and immunohistochemical
staining of lung and kidney at 72 hours after the CLP
procedure after treatment with one dose of ADMSC
The IHC staining showed that the number of alveolar
sacs in lung parenchyma was highest in SC and lowest
in CLP only, and significantly lower in CLP +H-ADMSC
than in CLP + A-ADMSC at 72 hours after the CLP
procedure (Figure 13A to 13F) after one dose of ADMSC
treatment. Conversely, the crowded score of lung paren-
chyma (Figure 13A to 13F) and the kidney injury score
(Figure 13G to 13J) were lowest in SC and highest in CLP
only, and significantly higher in CLP +H-ADMSC than in
CLP +A-ADMSC at 72 hours after the CLP procedure.
Additionally, the IF staining revealed that the infiltration
of CD68+ cells, an index of inflammatory cells in lung
(Figure 14A to 14E) and kidney (14-F to 14-J) paren-
chyma, displayed a pattern identical to the kidney injury
score at 72 hours after the CLP procedure. These findings
indicate that one dose of both H-ADMSC and A-ADMSC
significantly effectively attenuated sepsis-induced lung
and kidney parenchymal injury and inflammatory response,
Figure 10 Immunohistochemical (IHC) staining for kidney expressions of anti-oxidative markers at 72 hours after the CLP procedure. A
to D) Microscopic findings of IHC stain (200x) for glutathione reductase (GR)-positive cells (brown) in renal parenchyma of the four groups. Scale
bars in the right lower corner represent 50 μm. E) * versus other groups with different symbols (*, †, ‡), P <0.0001. F to I) Microscopic findings of
IHC stain (200x) for glutathione peroxidase (GPx)-positive cells (brown) in renal parenchyma of the four groups. Scale bars in the right lower
corner represent 50 μm. J) * versus other groups with different symbols (*, †, ‡, ¶), P <0.0001. All statistical analyses using one-way ANOVA,
followed by the Bonferroni multiple comparison post hoc test (n = 8). Symbols (*, †, ‡, §) indicate significance (at 0.05 level). SC ,sham control; CLP,
cecal ligation and puncture; H-ADMSC, healthy adipose-derived mesenchymal stem cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem
cell. ANOVA, analysis of variance.
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with A-ADMSC.Discussion
This study, which investigated the damage caused by
the CLP-induced sepsis syndrome in the lung and kidney
and the therapeutic impact of ADMSC, produced several
striking implications. First, our experimental study
demonstrated that ALI and AKI caused by damage
from CLP-induced sepsis syndrome were inevitable.
Second, A-ADMSC was superior to H-ADMSC in re-
ducing sepsis-induced ALI and AKI. Third, as com-
pared with H-ADMSC, A-ADMSC treatment was not
only more effective, but also more consistent in reducinginflammation, oxidative stress, apoptosis and histopatho-
logical perturbations in the lungs and kidneys.
Laboratory findings in the present study revealed
abnormally elevated circulating levels of creatinine,
TNF-α and white blood cell count as well as notably
decreased SBP following CLP-induced sepsis syndrome.
Undoubtedly, these experimental findings are consistent
with those in the clinical setting of severe sepsis.
The principal finding in the present study is the histo-
pathological picture of substantially aggravated pulmonary
(that is, increased crowded score and reduced number
of alveolar sacs) and renal (increased damage scores and
γ-H2AX-positively stained cells) parenchymal damage
caused by CLP-induced sepsis syndrome. Previous studies
have demonstrated that ALI and AKI commonly encoun-
Figure 11 Histopathological changes and inflammatory cell infiltration in lung parenchyma at 72 hours after the CLP procedure. A to
D) Microscopic findings of H & E stain (100x) of lung parencyma at 72 hours after the procedure. Scale bars in the right lower corners represent
100 μm. E) Quantitative analysis of the number of alveolar sacs. * versus other groups with different symbols (*, †, ‡, §), P <0.0001. F) Quantitative
analysis of crowded score. * versus other groups with different symbols (*, †, ‡, §), P <0.001. G to J) Immunohistochemical stain (200x) for CD3+ cells in
lung parencyma at 72 hours after the procedure. Scale bars in right lower corners represent 50 μm. K) Quantitative analysis of CD3+ cells. * versus
other groups with different symbols (*, †, ‡, §), P <0.0001. All statistical analyses using one-way ANOVA, followed by the Bonferroni multiple comparison
post hoc test (n = 8). Symbols (*, †, ‡, §) indicate significance (at 0.05 level). SC, sham control; CLP, cecal ligation and puncture; H-ADMSC, healthy
adipose-derived mesenchymal stem cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variance.
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were strongly associated with poor prognostic outcomes
[6,9-15]. Our findings, therefore, strengthen those of the
previous studies [6,9-15].
Experimental studies have revealed that stem cell treat-
ment significantly reduced sepsis-induced organ/tissue
damage through attenuating the inflammatory response
and the generation of oxidative stress which, in turn,
improved the prognostic outcome [23-25]. Moreover, grow-
ing evidence has shown that apoptotic/dying stem cells
possess a distinctive capacity of immunomodulation [21].
Furthermore, our recent study [22] has demonstrated that,
as compared with H-ADMSC+melatonin, A-ADMSC+
melatonin was more effective in reducing acute IR lung
injury. Surprisingly, whether A-ADMSC is superior to
H-ADMSC in protection against sepsis syndrome-inducedlung and kidney injuries has not been investigated. The
most important finding in the present study is that treat-
ment with A-ADMSC was found to be more effective
than that with H-ADMSC in suppressing the levels of
inflammation, apoptosis and oxidative stress as well as
in enhancing anti-oxidation and anti-apoptosis in a rodent
model of sepsis syndrome. The findings may account for
the enhanced effectiveness of treatment with A-ADMSC
compared to that with H-ADMSC in attenuating lung
and kidney parenchymal injury in this experimental setting.
Taken together, our results, in addition to reinforcing
those of our recent study [22], also extend the findings
of previous studies [21,23-25] and highlight the thera-
peutic potential of A-ADMSC in patients with severe
sepsis/septic shock unresponsive to traditional anti-
biotic treatment.
Figure 12 The protein expressions of oxidative stress and inflammatory biomarkers in both lung and kidney at 72 hours after the CLP
procedure with one dose of ADMSC treatment. The protein expressions of oxidized protein (A, F), matrix metalloproteinase (MMP)-9 (B, G),
intercellular adhesion molecule (ICAM) (C, H), tumor necrosis factor alpha (TNF-α) (D, I), and nuclear factor (NF)- κB (E, J) in lung and kidney were
highest in CLP and lowest in SC, and significantly higher in CLP + H-ADMSC than in CLP + A-ADMSC (all P values <0.005). * versus other groups
with different symbols (*, †, ‡, §), P <0.005. DNP, 1–3 dinitrophenylhydrazone; M.W., molecular weight (Note: Right lane and left lane shown on
the upper panel represent control oxidized molecular protein standard and protein molecular weight marker, respectively). 1, sham control (SC);
2, cecal ligation and puncture (CLP); 3, CLP + H-ADMSC; 4, CLP + A-ADMSC. All statistical analyses using one-way ANOVA, followed by the Bonferroni
multiple comparison post hoc test (n = 6). Symbols (*, †, ‡, §) indicate significance (at 0.05 level). SC, sham control; CLP, cecal ligation and puncture;
H-ADMSC, healthy adipose-derived mesenchymal stem cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variance.
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the positive therapeutic impact of H-ADMSC treatment
on acute IR-induced organ injury [16,18,22]. Unexpectedly,
in the current study (that is, a setting of CLP-induced sepsis
syndrome), treatment at three-time points with H-ADMSC
(total 3.6 × 106 cells, that is, a relatively high dosage), butnot A-ADMSC, showed inconsistent therapeutic actions
against inflammation, apoptosis and oxidative stress, as
well as in enhancing the generation of anti-apoptotic
and anti-oxidant biomarkers in both pulmonary and
renal parenchyma. However, as compared with untreated
CLP, one low-dose H-ADMSC treatment (that is, 1.2 × 106
Figure 13 Histopathological changes in lung and kidney at 72 hours after the CLP procedure with one dose of ADMSC treatment. A to
D) Microscopic findings of H & E stain (100x) of lung parenchyma at 72 hours after the procedure. Scale bars in the right lower corners represent
100 μm. E) Quantitative analysis of the number of alveolar sacs. * versus other groups with different symbols (*, †, ‡, §), P <0.001. F) Quantitative
analysis of crowded score. * versus other groups with different symbols (*, †, ‡, §), P <0.001. G to J) H & E stain (200x) showing the pathological
findings in kidney at 72 hours after the CLP procedure. Scale bars in the right lower corners represent 50 μm. yellow arrows = loss of brush
border in renal tubules; blue arrows = dilatation of Bowman’s capsule. K) * versus other groups with different symbols (*, †, ‡, §), P <0.001. All
statistical analyses using one-way ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 6). Symbols (*, †, ‡, §) indicate
significance (at 0.05 level). SC, sham control; CLP, cecal ligation and puncture; H-ADMSC, healthy adipose-derived mesenchymal stem cell;
A-ADMSC ,apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis of variance.
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was found to reduce significantly the expressions of
inflammatory biomarkers and protect the lung and
kidney parenchyma from sepsis syndrome-induced injuries.
Our findings are, therefore, consistent with those of the
previous studies [16,18,22]. On the other hand, contrary
to the anti-inflammatory effect of A-ADMSCs, the admin-
istration of three high-doses of H-ADMSCs caused para-
doxical up-regulation in the expressions of inflammatory
markers in the present study that cannot be satisfactorily
explained. We propose three possible reasons that could
explain this phenomenon. First, we suggest that in host
response, particularly that which participates in the clear-
ance of the infectious agents/products, three doses ofH-ADMSC, especially the third dosage, might elicit a
hyper-reactive immune response that mimics delayed
hypersensitivity rather than immune desensitization.
Second, it may be that the dose of H-ADMSC used in
the study was just too high, and 30% of the apoptotic
cells just served to reduce the dose of live cells to a
better point on the dose–response curve. Therefore,
our additional studies, that is, with the lower dose, only
serve to give credence to this alternative explanation.
Interestingly, one recent study has demonstrated that an
elevated dose of ADMSC did not contribute to enhanced
protection against lung injury in the setting of sepsis
syndrome [29]. Of importance is the fact that an overdose
of cell treatment might even be harmful to the lung
Figure 14 Immunofluorescent staining for identifying infiltration of CD68+ cells in lung and kidney at 72 hours after the CLP
procedure with one dose of ADMSC treatment. A to D) and F to I) IF microscopic findings (200x) of the number of CD68+ cells (white
arrows indicate CD68+ cells) in lung and kidney parenchyma, respectively. Scale bars in the right lower corners represent 50 μm. E) and J)
Quantitative analysis of the number of CD68+ cells in lung and kidney, respectively. Yellow arrows indicated the ADMSCs. * versus other
groups with different symbols (*, †, ‡, §), P <0.0001. All statistical analyses using one-way ANOVA, followed by the Bonferroni multiple
comparison post hoc test (n = 6). Symbols (*, †, ‡, §) indicate significance (at 0.05 level). SC, sham control; CLP, cecal ligation and puncture;
H-ADMSC, healthy adipose-derived mesenchymal stem cell; A-ADMSC, apoptotic adipose-derived mesenchymal stem cell. ANOVA, analysis
of variance.
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therefore, at least in part, explain the findings of our study.
Third, perhaps another more convincing explanation is
that the ‘stress’ of serum deprivation served to prime the
surviving cells rather than that 30% of the stressed cell
apoptosis in our CLP model, making them more effective
to protect against organ damage.
This study has limitations. First, it was not designed to
investigate the long-term therapeutic effect of ADMSC
treatment against sepsis-induce pulmonary and renal par-
enchymal damage. Second, this study did not compare the
therapeutic effect of a single versus multiple doses of
ADMSC on outcomes after CLP-induced sepsis syndrome.
Third, this study did not induce 100% of the A-ADMSCsfor the treatment of sepsis syndrome. Therefore, we do
not know whether 100% of A-ADMSC is more effective
than the regimen of the present study for treating sepsis
syndrome.
Conclusions
Treatment with A-ADMSC was superior to that with H-
ADMSC in attenuating sepsis syndrome-induced lung
and kidney parenchymal injury through suppressing in-
flammation, apoptosis and oxidative stress as well as en-
hancing anti-oxidation and anti-apoptosis in a rodent
model. The optimal dose of ADMSC for the treatment
of different disease entities should be clarified in pre-
clinical study prior to its clinical application.
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